The interferon receptor pathway's role in response and resistance to PD-1 blockade

被引：0
|
作者：
Ribas, Antoni [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2017年 / 5卷 / 03期
关键词：
D O I：
10.1158/2326-6074.TUMIMM16-IA10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA10
引用
收藏
页数：2
相关论文
共 50 条
  • [41] High response rate to PD-1 blockade in desmoplastic melanomas
    Zeynep Eroglu
    Jesse M. Zaretsky
    Siwen Hu-Lieskovan
    Dae Won Kim
    Alain Algazi
    Douglas B. Johnson
    Elizabeth Liniker
    Rodrigo Ben Kong
    Suthee Munhoz
    Pier Federico Rapisuwon
    Bartosz Gherardini
    Xiaoyan Chmielowski
    I. Peter Wang
    Cody Shintaku
    Jeffrey A. Wei
    Richard W. Sosman
    Michael A. Joseph
    Matteo S. Postow
    Wen-Jen Carlino
    Richard A. Hwu
    Jane Scolyer
    Alistair J. Messina
    Georgina V. Cochran
    Antoni Long
    Nature, 2018, 553 : 347 - 350
  • [42] THE NSCLC MUTATIONAL LANDSCAPE INFLUENCES RESPONSE TO PD-1 BLOCKADE
    不详
    CANCER DISCOVERY, 2015, 5 (05) : 465 - 465
  • [43] TCR use and cytokine response in PD-1 blockade.
    Zaretsky, Jesse M.
    Blum, Steven M.
    Faja, Lidia Robert
    Emerson, Ryan O.
    Ribas, Antoni
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] CTLA-4 and PD-1 pathway blockade: combinations in the clinic
    Callahan, Margaret K.
    Postow, Michael A.
    Wolchok, Jedd D.
    FRONTIERS IN ONCOLOGY, 2015, 4
  • [45] High response rate to PD-1 blockade in desmoplastic melanomas
    Eroglu, Zeynep
    Zaretsky, Jesse M.
    Hu-Lieskovan, Siwen
    Kim, Dae Won
    Algazi, Alain
    Johnson, Douglas B.
    Liniker, Elizabeth
    Kong, Ben
    Munhoz, Rodrigo
    Rapisuwon, Suthee
    Gherardini, Pier Federico
    Chmielowski, Bartosz
    Wang, Xiaoyan
    Shintaku, I. Peter
    Wei, Cody
    Sosman, Jeffrey A.
    Joseph, Richard W.
    Postow, Michael A.
    Carlino, Matteo S.
    Hwu, Wen-Jen
    Scolyer, Richard A.
    Messina, Jane
    Cochran, Alistair J.
    Long, Georgina V.
    Ribas, Antoni
    NATURE, 2018, 553 (7688) : 347 - +
  • [46] Soluble serum markers predicting response to PD-1 blockade
    Hofbauer, J.
    Hauck, A.
    Matos, C.
    Regotta, S.
    Schulz, C.
    Mickler, M.
    Haferkamp, S.
    Kreutz, M.
    Schnell, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 118 - 118
  • [47] SMOKING HISTORY AND PD-1/PDL-1 PATHWAY BLOCKADE: PREDICTING RESPONSE TO TREATMENT IN METASTATIC CANCER
    Sullivan, C. M.
    Lu, J.
    Kucharczyk, J.
    Vesselinovitch, D.
    Khurana, N.
    Matrana, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 569 - 569
  • [48] Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment
    Wang, Qiaohong
    Wu, Xia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 46 : 210 - 219
  • [49] The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade
    Zhang, Yuchen
    Yang, Chen
    Xu, Yanchao
    Jiang, Xiang
    Shi, Jiajun
    Li, Binghua
    Yu, Decai
    BIOMOLECULES AND BIOMEDICINE, 2024,
  • [50] The role of the PD-1 pathway in autoimmunity and peripheral tolerance
    Fife, Brian T.
    Pauken, Kristen E.
    YEAR IN IMMUNOLOGY, 2011, 1217 : 45 - 59
12345